Semenciw R M, Le N D, Marrett L D, Robson D L, Turner D, Walter S D
Cancer Bureau, LCDC, Health Canada, Ottawa, ON, Canada K1A 0L2.
Stat Med. 2000;19(17-18):2437-49. doi: 10.1002/1097-0258(20000915/30)19:17/18<2437::aid-sim580>3.0.co;2-j.
The Canadian Cancer Incidence Atlas is among recent national atlases using incidence rather than mortality data. Methods used to assess the significance and spatial correlation of the age-standardized rates (ASIRs) for the 290 census divisions are described. The expected number of cases by area was used to determine cancer sites with sufficient cases to be mapped. ASIR significance was assessed using a simulation based on a Poisson distribution. The consistency of the observed case distributions with the Poisson distribution was examined. The bootstrap confidence interval (CI) for the ASIR developed by Swift was used in the atlas. Spatial correlation was assessed with Moran's I/I(max) and the significance determined by a simulation in order to allow for area population variation. Data quality indicators typically used for cancer registries were presented, supplemented by a registry questionnaire.
《加拿大癌症发病率地图集》是近期使用发病率而非死亡率数据的国家地图集之一。文中描述了用于评估290个普查区年龄标准化率(ASIRs)的显著性和空间相关性的方法。通过各地区的预期病例数来确定有足够病例数可绘制地图的癌症部位。使用基于泊松分布的模拟来评估ASIR的显著性。检验了观察到的病例分布与泊松分布的一致性。地图集中使用了斯威夫特开发的ASIR的自助置信区间(CI)。用莫兰指数I/I(最大值)评估空间相关性,并通过模拟确定其显著性,以考虑地区人口差异。列出了癌症登记处通常使用的数据质量指标,并辅以登记处调查问卷。